Sinclair Pharma, the dermatology and oral health medicines group, is to raise £25m to fund the purchase of two skincare drugs from Solvay, the Belgian pharmaceutical group.

The group also announced the departure of its chief executive Michael Flynn, who is retiring and will be replaced by Christopher Spooner, a co-founder of HealthCor Management, a healthcare private equity group.